StockWatch
·
Medical/Nursing Services
Quarterly ResultAug 10, 2026, 04:20 PM

U.S. Physical Therapy Q2 Revenue $214M, Adj. EBITDA $27M

AI Summary

U.S. Physical Therapy reported Q2 2026 total revenue of $214 million, an 8.5% increase year-over-year, with adjusted EBITDA at $27.0 million. Physical therapy revenue grew 8.4% to $182 million, driven by strong visit volumes and a record net rate of $107.59. The company integrated 31 clinics into hospital affiliations during the quarter, contributing $5.6 million in revenue, with 39 more expected in Q3. Despite headwinds from higher self-insured healthcare costs and upfront hiring for hospital transitions, the company reaffirmed its full-year 2026 adjusted EBITDA guidance of $102 million to $106 million, anticipating significant benefits from hospital affiliations in the second half of the year and into 2027.

Key Highlights

  • Q2 2026 Total Revenue: $214 million, up 8.5% year-over-year.
  • Q2 2026 Adjusted EBITDA: $27.0 million, up from $26.9 million year-over-year.
  • Q2 2026 Physical Therapy Revenue: $182 million, up 8.4% year-over-year.
  • Q2 2026 Physical Therapy Revenue per visit: $107.59, up $2.26 year-over-year.
  • Q2 2026 Earnings per share: $0.25, down from $0.58 year-over-year.
  • Reaffirmed FY 2026 Adjusted EBITDA guidance: $102 million to $106 million.
  • Acquired 12-clinic PT practice for $16.4 million, adding $12 million annual revenue.
  • Repurchased 306,000 shares for $19.2 million at an average price of $62.80.